AMICUS THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Amicus Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Amicus Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $18.7M, a 13.2% increase year-over-year.
  • Amicus Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $83.8M, a 3.26% decline year-over-year.
  • Amicus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $86.1M, a 12.5% increase from 2022.
  • Amicus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $76.5M, a 32.3% increase from 2021.
  • Amicus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $57.8M, a 17.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $86.1M +$9.57M +12.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $76.5M +$18.7M +32.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $57.8M +$8.69M +17.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $49.2M +$4.72M +10.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $44.4M +$15.2M +51.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $29.3M +$6.16M +26.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $23.1M +$5.6M +32% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $17.5M +$7.53M +75.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $9.97M +$3.96M +66% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $6.01M -$169K -2.74% Jan 1, 2014 Dec 31, 2014 10-K/A 2017-03-03
2013 $6.18M -$14K -0.23% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $6.19M -$2.49M -28.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-03
2011 $8.68M +$2.48M +40% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $6.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.